Xia Feng Selected Research

Temozolomide (Temodar)

4/2024

UBE2C enhances temozolomide resistance by regulating the expression of p53 to induce aerobic glycolysis in glioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xia Feng Research Topics

Disease

14	Infections 01/2024 - 11/2006
11	Neoplasms (Cancer) 12/2023 - 09/2004
7	Chronic Hepatitis B 05/2019 - 08/2009
6	Inflammation (Inflammations) 09/2023 - 01/2012
5	Pain (Aches) 04/2024 - 01/2019
5	Wounds and Injuries (Trauma) 01/2024 - 01/2022
4	Hepatitis B 02/2015 - 01/2005
4	Autoimmune Hepatitis 09/2011 - 12/2005
3	Necrosis 01/2024 - 10/2007
3	Diabetic Foot 01/2024 - 09/2023
3	Sleep Initiation and Maintenance Disorders (Insomnia) 07/2023 - 01/2019
3	COVID-19 07/2023 - 01/2021
3	Hepatocellular Carcinoma (Hepatoma) 01/2012 - 05/2008
3	Liver Cirrhosis (Hepatic Cirrhosis) 04/2007 - 01/2005
2	Glioma (Gliomas) 04/2024 - 10/2022
2	Ulcer 01/2024 - 12/2023
2	Lymphoma (Lymphomas) 11/2023 - 01/2022
2	Hyperalgesia 10/2023 - 08/2023
2	Postoperative Pain 08/2023 - 01/2019
2	Dysbiosis 05/2023 - 01/2023
2	Hemolysis 01/2023 - 02/2015
2	Schizophrenia (Dementia Praecox) 07/2022 - 01/2018
2	Ischemia 01/2022 - 03/2019
2	Fibrosis (Cirrhosis) 01/2022 - 01/2012
2	Cognitive Dysfunction 01/2021 - 01/2013
2	Hypertension (High Blood Pressure) 01/2020 - 01/2018
2	Carcinoma (Carcinomatosis) 03/2017 - 10/2007
2	Foot-and-Mouth Disease 01/2016 - 01/2016
2	Persistent Infection 01/2016 - 05/2008
2	Sepsis (Septicemia) 02/2015 - 12/2014
2	Foreign Bodies (Foreign Body) 03/2012 - 07/2011
2	Liver Diseases (Liver Disease) 09/2011 - 12/2005
1	Flatulence 04/2024
1	Hypothermia 01/2024
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 12/2023
1	Emergence Delirium 12/2023
1	Peripheral Arterial Disease 12/2023
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 11/2023
1	Hodgkin Disease (Hodgkin's Disease) 11/2023

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 04/2024 - 11/2006
6	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2018
5	AntibodiesIBA 01/2021 - 11/2006
4	Messenger RNA (mRNA)IBA 04/2024 - 05/2016
4	EnzymesIBA 11/2023 - 08/2009
4	Glucose (Dextrose)FDA LinkGeneric 09/2023 - 11/2010
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 04/2010
3	Analgesics (Analgesic Drugs)IBA 01/2024 - 10/2007
3	LigandsIBA 11/2023 - 01/2022
3	Morphine (MS Contin)FDA LinkGeneric 01/2023 - 01/2019
3	AntigensIBA 01/2021 - 05/2008
3	VaccinesIBA 01/2021 - 01/2016
3	Peptides (Polypeptides)IBA 10/2014 - 08/2009
3	AutoantibodiesIBA 09/2011 - 12/2005
3	liver antigen LA-1IBA 05/2011 - 12/2005
2	Hydrocortisone (Cortisol)FDA LinkGeneric 04/2024 - 10/2007
2	Interleukin-17 (Interleukin 17)IBA 12/2023 - 01/2022
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2023 - 10/2007
2	AcidsIBA 12/2023 - 01/2023
2	ImmunosorbentsIBA 11/2023 - 11/2022
2	ParaffinIBA 11/2023 - 01/2022
2	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 10/2023 - 01/2023
2	Blood Glucose (Blood Sugar)IBA 09/2023 - 11/2010
2	Hemoglobins (Hemoglobin)IBA 01/2023 - 01/2022
2	Androgen Receptors (Androgen Receptor)IBA 01/2023 - 01/2020
2	Antipsychotic Agents (Antipsychotics)IBA 07/2022 - 01/2018
2	RNA (Ribonucleic Acid)IBA 01/2022 - 12/2005
2	ORALIT (ORS)IBA 01/2020 - 01/2019
2	polyglutamineIBA 01/2020 - 05/2012
2	CytokinesIBA 05/2019 - 01/2012
2	Interleukin-6 (Interleukin 6)IBA 01/2019 - 10/2007
2	Sevoflurane (Ultane)FDA LinkGeneric 01/2018 - 08/2016
2	Propofol (Diprivan)FDA LinkGeneric 01/2018 - 10/2015
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 03/2017 - 05/2016
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 03/2017 - 10/2014
2	Antiviral Agents (Antivirals)IBA 02/2015 - 03/2012
2	Hepatitis B e AntigensIBA 02/2015 - 07/2013
2	AnticoagulantsIBA 02/2015 - 12/2014
2	Anesthetics (Anesthetic Agents)IBA 09/2014 - 03/2012
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2012 - 12/2005
2	Immunoglobulin G (IgG)IBA 04/2007 - 11/2006
2	Immunoglobulin M (IgM)IBA 11/2006 - 01/2005
2	GlucuronidesIBA 04/2005 - 09/2004
2	vadimezanIBA 04/2005 - 09/2004
1	Temozolomide (Temodar)FDA LinkGeneric 04/2024
1	GelatinIBA 01/2024
1	HydrogelsIBA 01/2024
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2024
1	Vasodilator Agents (Vasodilators)IBA 01/2024
1	Insulin (Novolin)FDA Link 01/2024
1	si-miao-yong-an decoctionIBA 12/2023

Therapy/Procedure

8	Therapeutics 01/2024 - 01/2012
3	Analgesia 10/2023 - 10/2007
3	Anesthesia 05/2023 - 03/2012
2	Length of Stay 04/2024 - 08/2023
2	Surgical Amputation (Amputations) 01/2024 - 12/2023
2	Drug Therapy (Chemotherapy) 11/2023 - 01/2022
2	General Anesthesia 01/2018 - 07/2011
1	Limb Salvage 01/2024
1	Debridement 01/2024
1	Resuscitation 01/2024